81 related articles for article (PubMed ID: 36114549)
1. Can HPV Selfy be considered as a clinically validated HPV test for use in cervical cancer screening?
Arbyn M; Bonde J; Cushieri K; Poljak M
J Transl Med; 2022 Sep; 20(1):422. PubMed ID: 36114549
[No Abstract] [Full Text] [Related]
2. Clinical validation of the cobas 4800 HPV test for cervical screening purposes.
Heideman DA; Hesselink AT; Berkhof J; van Kemenade F; Melchers WJ; Daalmeijer NF; Verkuijten M; Meijer CJ; Snijders PJ
J Clin Microbiol; 2011 Nov; 49(11):3983-5. PubMed ID: 21880968
[TBL] [Abstract][Full Text] [Related]
3. Validation of intra- and inter-laboratory reproducibility of the Xpert HPV assay according to the international guidelines for cervical cancer screening.
Akbari A; Vanden Broeck D; Benoy I; Padalko E; Bogers J; Arbyn M
Virol J; 2018 Oct; 15(1):166. PubMed ID: 30373616
[TBL] [Abstract][Full Text] [Related]
4. Recommendations for Implementing Human Papillomavirus-Based Cervical Cancer Screening: Lessons Learned from the HPV FOCAL Trial.
Smith L; van Niekerk D; Coldman A; Krajden M; Franco EL; Ogilvie G
J Obstet Gynaecol Can; 2016 Aug; 38(8):723-6. PubMed ID: 27638983
[No Abstract] [Full Text] [Related]
5. Urine-based HPV testing as a method to screen for cervical cancer.
Fontenot HB
Nurs Womens Health; 2015; 19(1):59-65. PubMed ID: 25690816
[TBL] [Abstract][Full Text] [Related]
6. Effect of HPV on cervical cancer screening in Alberta.
Brisson M; Drolet M; Bénard É; Kreimer AR
CMAJ; 2016 Oct; 188(14):1035. PubMed ID: 27698024
[No Abstract] [Full Text] [Related]
7. Cervical cancer screening in the era of human papillomavirus testing and vaccination.
Murphy J; Mark H
J Midwifery Womens Health; 2012; 57(6):569-576. PubMed ID: 23050698
[TBL] [Abstract][Full Text] [Related]
8. Self-collection for HPV screening: a game changer in the elimination of cervical cancer.
Canfell K; Smith MA; Bateson DJ
Med J Aust; 2021 Oct; 215(8):347-348. PubMed ID: 34499374
[No Abstract] [Full Text] [Related]
9. Evaluation of the Clinical Performance of the HPV-Risk Assay Using the VALGENT-3 Panel.
Polman NJ; Oštrbenk A; Xu L; Snijders PJF; Meijer CJLM; Poljak M; Heideman DAM; Arbyn M
J Clin Microbiol; 2017 Dec; 55(12):3544-3551. PubMed ID: 29021152
[TBL] [Abstract][Full Text] [Related]
10. The rationale for implementation of HPV testing in routine cervical screening in Romania.
Iancu LS; Ursu RG
Rev Med Chir Soc Med Nat Iasi; 2013; 117(2):293-6. PubMed ID: 24340506
[No Abstract] [Full Text] [Related]
11. [Cervical cancer screning: from cytology to HPV testing].
Wei LH
Zhonghua Fu Chan Ke Za Zhi; 2019 May; 54(5):289-292. PubMed ID: 31154708
[TBL] [Abstract][Full Text] [Related]
12. Factors associated with human papillomavirus (HPV) test acceptability in primary screening for cervical cancer: A mixed methods research synthesis.
Tatar O; Thompson E; Naz A; Perez S; Shapiro GK; Wade K; Zimet G; Gilca V; Janda M; Kahn J; Daley E; Rosberger Z
Prev Med; 2018 Nov; 116():40-50. PubMed ID: 30172799
[TBL] [Abstract][Full Text] [Related]
13. [HPV screening for cervical cancer--the calculation of the Swedish National Board of Health and Welfare is too pessimistic].
Wilander E
Lakartidningen; 2015 Dec; 112():. PubMed ID: 26625106
[No Abstract] [Full Text] [Related]
14. HPV screening for cervical cancer is reaching maturity.
Canfell K; Smith M; Saville M; Arbyn M
BMJ; 2022 May; 377():o1303. PubMed ID: 35640961
[No Abstract] [Full Text] [Related]
15. Clinical validation of the HPV-risk assay, a novel real-time PCR assay for detection of high-risk human papillomavirus DNA by targeting the E7 region.
Hesselink AT; Berkhof J; van der Salm ML; van Splunter AP; Geelen TH; van Kemenade FJ; Bleeker MG; Heideman DA
J Clin Microbiol; 2014 Mar; 52(3):890-6. PubMed ID: 24391196
[TBL] [Abstract][Full Text] [Related]
16. Primary human papillomavirus testing in organized cervical screening.
Dillner J
Curr Opin Obstet Gynecol; 2013 Feb; 25(1):11-6. PubMed ID: 23299089
[TBL] [Abstract][Full Text] [Related]
17. [Guidelines for HPV screening should be reconsidered].
Fröberg M; Östensson E; Alder S; Andersson S
Lakartidningen; 2015 Dec; 112():. PubMed ID: 26625108
[No Abstract] [Full Text] [Related]
18. Patient safety and the next generation of HPV DNA tests.
Lee SH
Am J Clin Pathol; 2011 Mar; 135(3):481; author reply 482-3. PubMed ID: 21350106
[No Abstract] [Full Text] [Related]
19. Yes! To Scaling Up Cervical Cancer Screening With Self-Collection: But the Cost of HPV Screening Must Be Reduced.
Beddoe AM
JCO Glob Oncol; 2021 Aug; 7():1327-1328. PubMed ID: 34436925
[No Abstract] [Full Text] [Related]
20. Randomized controlled trial of human papillomavirus testing versus Pap cytology in the primary screening for cervical cancer precursors: design, methods and preliminary accrual results of the Canadian cervical cancer screening trial (CCCaST).
Mayrand MH; Duarte-Franco E; Coutlée F; Rodrigues I; Walter SD; Ratnam S; Franco EL;
Int J Cancer; 2006 Aug; 119(3):615-23. PubMed ID: 16572425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
